For HCC patients, it is known that baseline α-fetoprotein concentration and other biomarkers such as miR-26 miRNA precursor, epithelial cell adhesion molecule are suggested to be correlated with the outcomes (35, 36). This evidence concerns the gene EPCAM and hepatocellular carcinoma.